Слот Big Bamboo: что нужно знать

Слот Big Bamboo появился в 2023 г.и сразу привлёк внимание казахстанских онлайн‑казино.Его создатель – компания Big Bamboo Interactive – обещает яркую графику и хорошую доходность.В статье разберём, чем он отличается от лидера рынка – Volta Casino – и какие реальные впечатления оставили игроки из Алматы и Астаны.

Игровой процесс и механика

Слот использует классическую схему 5 барабанов и 25 линий выплат.Каждый барабан содержит 10 символов, в том числе Wild и Scatter.Игрок может выбрать до 25 активных линий и ставку от 0,1 тг до 5 000 тг.Такая ценовая диапазон делает игру доступной как для новичков, так и для тех, кто ищет крупные выплаты.

Бесплатные спины в слоте биг бамбу повышают шанс крупного выигрыша: в big bamboo играть.Механика “мульти‑спин” позволяет такую удерживать выигрышные комбинации на нескольких барабанах одновременно, повышая вероятность бонусных раундов и увеличивая средний размер выигрыша.

Графика и звуковое сопровождение

Тропический лес и огромный бамбук – главные визуальные темы.Анимации, световые вспышки и динамичные фоны создают ощущение живого леса.Звуковая дорожка – смесь азиатских инструментов и природных звуков, подчёркивающая атмосферу.Пользователи отмечают, что частота кадров 60 fps делает игровой процесс плавным даже на мобильных устройствах.

Бонусные функции и возможности выигрыша

Scatter‑бонус

Три и более Scatter открывают 10-20 бесплатных спинов.В бонусном раунде Wild заменяет любые символы, повышая шансы на крупные выигрыши.

Гибкая система Wild

Wild заменяет все символы, кроме Scatter, и активирует “Wild‑мультипликатор” до 5 × базовой ставки.

“Флора” – уникальный раунд

При активации “Флоры” игрок выбирает один из пяти бонусных символов.Каждый символ даёт разный приз: дополнительные бесплатные спины, повышенный множитель, мгновенный выигрыш и т.д.

Кэш‑бэк

В течение первых 30 дней после регистрации игрок получает кэш‑бэк 5% от проигранной суммы, что снижает риск потерь и повышает лояльность.

Лицензирование и безопасность

Слот доступен на платформе https://bigbambooigrat.kz/app/.Оператор использует лицензии от Мальтийского игрового управления (MGA) и Гибралтарского регулятора, что гарантирует честность игры и защиту личных данных.Транзакции шифруются протоколом SSL 256‑бит, а RNG проходит регулярный аудит у независимых компаний, таких как eCOGRA.

Сравнение с Volta Casino

Фактор Big Bamboo Volta Casino
RTP 96,5% 97,2%
Волатильность Средняя Высокая
Максимальный выигрыш 50 000 тг 120 000 тг
Бонусные спины 10-20 15-25
Мобильная совместимость Полнейшая Полнейшая
Лицензии MGA, Гибралтар MGA, Мальта
Время отклика 0,02 с 0,01 с
Программа лояльности Кэш‑бэк 5% Триуровневая система баллов

Эксперт: “Volta Casino действительно привлекает игроками более высокую доходность, но Big Bamboo выигрывает в части доступности и бонусных возможностей.Для тех, кто предпочитает умеренный риск и более частые выигрыши, это отличный выбор”, – отмечает аналитик Ирина Смирнова.

Практический опыт игроков в Казахстане

Присоединяйтесь к игрокам в big bamboo играть и испытайте удачу в слоте биг бамбу.В Алматы Сергей за первый месяц игры на Big Bamboo заработал 50 000 тг, используя бонусный раунд “Флора”.Он сказал: “Бонусные спины приходятся чаще, чем в Volta, и это делает игру более динамичной”.

В Астане Марина воспользовалась кэш‑беком 5% после 30 дней, что позволило ей вернуть часть проигранной суммы и продолжить игру с более низкой ставкой.Это подчёркивает, как Big Bamboo привлекает игроков своей гибкой системой вознаграждений.

Ключевые моменты

  • Доступность: Минимальная ставка 0,1 тг делает игру доступной для широкой аудитории.
  • Присоединяйтесь к игрокам https://cichlidka.com.ua и испытайте удачу в слоте биг бамбу.Бонусные раунды: Scatter‑бонус и уникальный раунд “Флора” повышают частоту выигрышей.
  • Сравнение с лидером: Хотя Volta Casino лидирует по RTP, Big Bamboo предлагает более частые и разнообразные бонусы.
  • Безопасность: Лицензии MGA и Гибралтар, а также аудит RNG обеспечивают честность игры.
  • Реальный опыт: Примеры из жизни казахстанских игроков подтверждают эффективность бонусных программ и привлекательность игры.

С учётом всех факторов, слот Big Bamboo представляет собой достойную альтернативу традиционным играм на рынке казахстанских онлайн‑казино.Он сочетает привлекательную графику, гибкую систему бонусов и высокий уровень безопасности, что делает его интересным как для новичков, так и для опытных игроков, ищущих новые возможности для выигрыша.

Слот Big Bamboo: что нужно знать

Слот Big Bamboo появился в 2023 г.и сразу привлёк внимание казахстанских онлайн‑казино.Его создатель – компания Big Bamboo Interactive – обещает яркую графику и хорошую доходность.В статье разберём, чем он отличается от лидера рынка – Volta Casino – и какие реальные впечатления оставили игроки из Алматы и Астаны.

Игровой процесс и механика

Слот использует классическую схему 5 барабанов и 25 линий выплат.Каждый барабан содержит 10 символов, в том числе Wild и Scatter.Игрок может выбрать до 25 активных линий и ставку от 0,1 тг до 5 000 тг.Такая ценовая диапазон делает игру доступной как для новичков, так и для тех, кто ищет крупные выплаты.

Бесплатные спины в слоте биг бамбу повышают шанс крупного выигрыша: в big bamboo играть.Механика “мульти‑спин” позволяет такую удерживать выигрышные комбинации на нескольких барабанах одновременно, повышая вероятность бонусных раундов и увеличивая средний размер выигрыша.

Графика и звуковое сопровождение

Тропический лес и огромный бамбук – главные визуальные темы.Анимации, световые вспышки и динамичные фоны создают ощущение живого леса.Звуковая дорожка – смесь азиатских инструментов и природных звуков, подчёркивающая атмосферу.Пользователи отмечают, что частота кадров 60 fps делает игровой процесс плавным даже на мобильных устройствах.

Бонусные функции и возможности выигрыша

Scatter‑бонус

Три и более Scatter открывают 10-20 бесплатных спинов.В бонусном раунде Wild заменяет любые символы, повышая шансы на крупные выигрыши.

Гибкая система Wild

Wild заменяет все символы, кроме Scatter, и активирует “Wild‑мультипликатор” до 5 × базовой ставки.

“Флора” – уникальный раунд

При активации “Флоры” игрок выбирает один из пяти бонусных символов.Каждый символ даёт разный приз: дополнительные бесплатные спины, повышенный множитель, мгновенный выигрыш и т.д.

Кэш‑бэк

В течение первых 30 дней после регистрации игрок получает кэш‑бэк 5% от проигранной суммы, что снижает риск потерь и повышает лояльность.

Лицензирование и безопасность

Слот доступен на платформе https://bigbambooigrat.kz/app/.Оператор использует лицензии от Мальтийского игрового управления (MGA) и Гибралтарского регулятора, что гарантирует честность игры и защиту личных данных.Транзакции шифруются протоколом SSL 256‑бит, а RNG проходит регулярный аудит у независимых компаний, таких как eCOGRA.

Сравнение с Volta Casino

Фактор Big Bamboo Volta Casino
RTP 96,5% 97,2%
Волатильность Средняя Высокая
Максимальный выигрыш 50 000 тг 120 000 тг
Бонусные спины 10-20 15-25
Мобильная совместимость Полнейшая Полнейшая
Лицензии MGA, Гибралтар MGA, Мальта
Время отклика 0,02 с 0,01 с
Программа лояльности Кэш‑бэк 5% Триуровневая система баллов

Эксперт: “Volta Casino действительно привлекает игроками более высокую доходность, но Big Bamboo выигрывает в части доступности и бонусных возможностей.Для тех, кто предпочитает умеренный риск и более частые выигрыши, это отличный выбор”, – отмечает аналитик Ирина Смирнова.

Практический опыт игроков в Казахстане

Присоединяйтесь к игрокам в big bamboo играть и испытайте удачу в слоте биг бамбу.В Алматы Сергей за первый месяц игры на Big Bamboo заработал 50 000 тг, используя бонусный раунд “Флора”.Он сказал: “Бонусные спины приходятся чаще, чем в Volta, и это делает игру более динамичной”.

В Астане Марина воспользовалась кэш‑беком 5% после 30 дней, что позволило ей вернуть часть проигранной суммы и продолжить игру с более низкой ставкой.Это подчёркивает, как Big Bamboo привлекает игроков своей гибкой системой вознаграждений.

Ключевые моменты

  • Доступность: Минимальная ставка 0,1 тг делает игру доступной для широкой аудитории.
  • Присоединяйтесь к игрокам https://cichlidka.com.ua и испытайте удачу в слоте биг бамбу.Бонусные раунды: Scatter‑бонус и уникальный раунд “Флора” повышают частоту выигрышей.
  • Сравнение с лидером: Хотя Volta Casino лидирует по RTP, Big Bamboo предлагает более частые и разнообразные бонусы.
  • Безопасность: Лицензии MGA и Гибралтар, а также аудит RNG обеспечивают честность игры.
  • Реальный опыт: Примеры из жизни казахстанских игроков подтверждают эффективность бонусных программ и привлекательность игры.

С учётом всех факторов, слот Big Bamboo представляет собой достойную альтернативу традиционным играм на рынке казахстанских онлайн‑казино.Он сочетает привлекательную графику, гибкую систему бонусов и высокий уровень безопасности, что делает его интересным как для новичков, так и для опытных игроков, ищущих новые возможности для выигрыша.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.